Hydroxyectoine overproduction by the natural producer Chromohalobacter salexigens is presented in this study. Genetically engineered strains were constructed that at low salinity coexpressed, in a vector derived from a native plasmid, the ectoine (ectABC) and hydroxyectoine (ectD) genes under the control of the ectA promoter, in a temperature-independent manner. Hydroxyectoine production was further improved by increasing the copies of ectD and using a C. salexigens genetic background unable to synthesize ectoines.
ctoine and hydroxyectoine (ectoines) are compatible solutes synthesized and accumulated by halophilic and halotolerant bacteria in response to osmotic and heat stress (1, 2) . Ectoines have current applications as biostabilizers of proteins and nucleic acids, as well as a potential role as therapeutics for certain diseases (3, 4) . This, together with the complexity of their chemical synthesis, has encouraged recent efforts to improve ectoine production from bacteria. Hydroxyectoine is especially interesting, as it seems to confer additional protections derived from its hydroxylated nature (3, 4) . Ectoines are synthesized from aspartate semialdehyde. First, this metabolite is converted into diaminobutyric acid, which is acetylated to N␥-acetyldiaminobutyric acid and subsequently cycled to ectoine (5, 6) . The main route of hydroxyectoine synthesis is via ectoine hydroxylation (2) . The enzymes for ectoine synthesis are usually encoded in an ectABC-type gene cluster, which is usually well conserved among ectoine-producing microorganisms (7) . There are exceptions, such as incomplete operons, gene clusters including the ask gene (for the aspartate kinase), gene clusters carrying ectABC-ectD-ask, and scattering of the genes within the chromosome, with duplications of ectC and ectD or even solitary ectC (5, 7, 8) . Industrial production of hydroxyectoine uses Halomonas elongata ATCC 33173 T grown under high-salinity and high-temperature conditions, using the bacterial milking method (9) , or a derivative of this technique (10), followed by separation and purification of ectoine and hydroxyectoine (9) . This salt and temperature requirement for hydroxyectoine synthesis is a serious drawback of using natural producers, since fermentation under high temperature and salinity increases production costs and corrodes industrial reactors.
Chromohalobacter salexigens is a halophilic gammaproteobacterium which produces ectoine and hydroxyectoine in response to salt and heat stress, respectively (7) . It is easy to grow and its genome sequence is available (http://genome.ornl.gov/microbial /csal/). It has been suggested as an alternative to H. elongata (11) . In C. salexigens, the genes encoding ectoine synthesis lay within a 2.8-kb region encoding the diaminobutyric acid acetyltransferase (EctA), diaminobutyric acid transaminase (EctB), and ectoine synthase (EctC) (12) . The microorganism has two paralogs of the enzyme ectoine hydroxylase, EctD and EctE, but EctD is the main responsible enzyme for hydroxyectoine production (2). In C. salexigens, the gene cluster ectABC and the genes ectD and ectE are at different loci within the chromosome.
Whereas accumulation of both solutes in C. salexigens is maximal during stationary phase, the accumulation of hydroxyectoine is upregulated by salinity and temperature, and the accumulation of ectoine is upregulated by salinity and downregulated by temperature. Thus, hydroxyectoine production and accumulation is maximum at 45°C and 14.5% NaCl, while ectoine accumulation reaches its maximum at 37°C and 17.4% NaCl (2) . This regulation occurs, at least in part, at the transcriptional level. The ectoine synthesis genes ectABC can be expressed from two promoter regions, one located upstream of ectA and composed of four putative promoters (PectA1 to PectA4 [PectA1-4]) and a second internal promoter located upstream of ectB (PectB). In silico analysis of the Ϫ10 and Ϫ35 sequences of these regions showed that PectA1 and PectA2 may be dependent on the main vegetative factor 70 (and therefore constitutively expressed), whereas PectA3 and PectB were similar to S -and 32 -dependent promoters, respectively. In agreement with these predictions, expression of a PectA1-4::lacZ fusion was osmoregulated and depended in part on the general stress factor S , whereas PectB was induced by continuous growth at a high temperature (13) . On the other hand, the promoter region of ectD is composed of two promoters (PectD1 and PectD2), and ectD expression is both osmo-and thermoregulated (M. Reina-Bueno, unpublished data).
In this work, we have metabolically engineered C. salexigens to overproduce hydroxyectoine at low salinity, in a temperature-independent manner. In order to maximize hydroxyectoine production and to minimize its temperature and salinity requirements, we designed transcriptional fusions between the ectoine synthesis genes ectABC and the main hydroxyectoine synthesis gene ectD, so that the second became transcriptionally controlled by the ectABC promoter region. To construct a functional ectABCD cassette, we first amplified by PCR a 3,384-bp sequence, including the promoter region upstream of ectA, the ectABC gene cluster, and the rho-independent terminator downstream of ectC, and cloned it into pBluescript SK, resulting in pME2. Then, we inserted a BamHI restriction site between ectC and the rho-independent terminator by site-directed mutagenesis using the primer pair ectBam_fw and ectBam_rv (see Table S1 in the supplemental material for a list of primers used in this study). Subsequently, we eliminated the BamHI restriction site from the multicloning site of pBluescript SK using the primers QuitBam_fw and QuitBam_rv, getting pME2.3. Next, we amplified a 1,200-bp sequence from the C. salexigens genome, including ectD, and inserted it into pBluescript SK, getting the plasmid pECTD. Then, we introduced a BclI restriction site downstream of ectD using the primers ectDBcl_fw and ectDBcl_rv, resulting in pECTD2. Subsequently, we excised promoterless ectD from pECTD2 by digesting it with BclI and inserted it in BamHIdigested pME2.3, yielding pECTABCD. Finally, the engineered ectABCD gene cluster was excised from pECTABCD by digestion with EcoRI and cloned into EcoRI-digested pHS15 (a cloning and expression vector based on a native plasmid from H. elongata harboring a streptomycin resistance gene [14] ), obtaining pHYDROX1 (Fig. 1A) . To increase the ectD gene dose, a second functional cassette, ectABCDD, was constructed. For this purpose, a second copy of ectD was cloned between ectD and the rho-independent terminator in the previous ect-ABCD-constructed gene cluster. First, we introduced a BamHI restriction site between ectD and the rho-independent terminator in pECTABCD, using the primers ABCDBam_fw and ABCDBam_rv, getting pME2.4. Then, an internal BamHI site of ectD was eliminated by introducing a silent mutation with the primers QuitBamD_fw and QuitBamD_rv, resulting in pME2.5. Next, ectD was excised from pECTD2 with BclI and cloned in BamHI-digested pME2.5, resulting in pECTABCDD. Subsequently, the ectABCDD synthetic gene cluster was excised by digestion with EcoRI from pECTABCDD and cloned in EcoRI-digested pHS15, resulting in pHYDROX2 (Fig. 1B) . Both plasmids pHYDROX1 and pHYDROX2 were transformed into Escherichia coli DH5␣ cells, and the resulting strains were used as donors in a conjugation with C. salexigens wild type and mutant CHR137 (⌬ectABC::Tn1732, ectD::⍀; unable to synthesize ectoines) (2) .
To evaluate hydroxyectoine production in both the natural producer C. salexigens and the heterologous host E. coli DH5␣, we determined the ectoine content in all strains containing pHY-DROX1 and pHYDROX2. For this purpose, cells were grown at different temperatures (37°C for E. coli and 37, 40, and 45°C for C. salexigens) in shaking flasks with minimal medium M63 added with 20 mM glucose and different salinities (1%, 2%, or 3% NaCl for E. coli strains and 4.35%, 8.7%, or 14.5% NaCl for C. salexigens strains) until early stationary phase. Cellular extracts used for liquid chromatography-mass spectrometry (LC-MS) and supernatants used for high-pressure liquid chromatography with UV detector (HPLC-UV) analysis of ectoine and hydroxyectoine were prepared by using a modified Bligh-Dyer technique described by Kraegeloh and Kunte (15) . For cellular extracts, chromatographic separation and HPLC-electrospray ionization was performed as described by Argandoña et al. (16) . For supernatants, samples were analyzed as described by García-Estepa et al. (2) .
Hydroxyectoine levels observed in the heterologous recombinant strains E. coli DH5␣/pHYDROX1 and E. coli DH5␣/ pHYDROX2 grown at 1%, 2%, or 3% NaCl were very low, and only traces of ectoine were detected (data not shown). Table 1 summarizes growth rates and ectoine and hydroxyectoine production by the different C. salexigens wild-type and recombinant strains, as well as their specific production rates. As production of ectoines is directly related to the biomass produced at a certain salinity (11), the specific production rate (mol/g bacterial dry matter [BDM] · h) is a simple function reflecting solute content and growth rate (17) . As previously reported (2), ectoine accumulation by C. salexigens wild type was salinity dependent and, at a given salinity, inversely correlated to increasing temperature. Ectoine reached its maximal accumulation (725 mol/g BDM) at 37°C with 14.5% of NaCl, with an ectoine/hydroxyectoine ratio of 2.24:1. On the other hand, hydroxyectoine accumulation by the wild type was salinity and temperature dependent, reaching its maximum at 45°C with 14.5% NaCl, with an ectoine/hydroxyectoine ratio of 0.45:1 and a yield of 942 mol/g BDM.
All C. salexigens recombinant strains carrying plasmids pHYDROX1 or pHYDROX2, grown at 37°C or 40°C with 4.35% or 8.7% NaCl, showed much higher hydroxyectoine and much lower ectoine yields, respectively, than the wild-type strain carrying no plasmid under the same conditions. In all cases, the major product was hydroxyectoine, and the higher hydroxyectoine production was accompanied by a decrease of growth rates. This was correlated with the lower ectoine yields observed, confirming that ectoine is necessary for osmoprotection of C. salexigens. Otherwise, ectoine production by C. salexigens recombinant strains at 14.5% NaCl could not be measured, as they did not grow or showed only residual growth. For a given recombinant strain, growth at 40°C did not result in a significant increase of hydroxyectoine yield, if compared to the same strain grown at 37°C. This finding indicated that the higher hydroxyectoine synthesis in the engineered strains was mostly driven by the PectA promoter region and therefore decoupled from temperature control.
With the exception of cells grown at 40°C with 8.7% NaCl, in the wild-type background the presence of an extra copy of ectD (i.e., cells carrying pHYDROX2 versus cells carrying pHYDROX1 grown under the same conditions) did not improve hydroxyecto-ine yield. In addition, an increase in salinity (i.e., the same recombinant strain grown at 8.7% versus 4.35% NaCl at a given temperature) did not improve hydroxyectoine production in the wildtype background. However, in the ectoine-deficient strain CHR137 (2), incrementing ectD dose or salinity did enhanced hydroxyectoine yields. These findings suggest that control mechanisms ruled by endogenous ectABC and/or ectD genes are somehow repressing hydroxyectoine synthesis in the wild-type background.
The best production results were achieved with strain CHR137 carrying pHYDROX2. This strain grown at 8.7% NaCl reached a hydroxyectoine yield of 967 mol/g BDM (4.78-fold higher than that achieved by the wild-type strain at this salinity), with a total ectoine yield of 1,253 mol/g BDM (ectoine/hydroxyectoine ratio of 0.29:1) and a significant decrease of the growth rate (0.1 h Ϫ1 ) that reduced the specific production rate to 96.7 mol/g BDM · h. However, the same strain grown at 4.35% NaCl showed a hydroxyectoine yield of 883 mol/g BDM (14.96-fold higher than that observed in the wild-type strain at the same salinity), maintaining a reasonable growth rate (0.14 h Ϫ1 , with a specific production rate of 123.6 mol/g BDM · h) and reaching an ectoine/ hydroxyectoine ratio of 0.1:1. These production data at low salinity and optimal temperature are very similar to those shown by the wild type grown at high salinity and high temperature (14.5% NaCl and 45°C).
In most bacteria, the responses to osmotic and/or heat stress involve the synthesis of a cocktail of compatible solutes (7) . Thus, the presence of by-products other than ectoine was investigated in the most promising strain, CHR137/pHYDROX2, grown at 37°C with low salinity and compared to the cytoplasmic solute pool synthesized by the wild type carrying either pHYDROX2 or no plasmid. As shown in Fig. S1 in the supplemental material, the major compatible solute in C. salexigens wild-type cells grown at 37°C with 4.35% NaCl was ectoine, followed by glutamate and minor amounts of glucosylglycerol and hydroxyectoine. Introduction of pHYDROX2 in wild-type cells switched the synthesis to hydroxyectoine, which became the major compatible solute, followed by glutamate, trehalose, and minor amounts of glucosylglycerol and ectoine. The presence of trehalose in the wild type overexpressing hydroxyectoine at 37°C was unexpected, as this sugar is synthesized by C. salexigens in response to heat stress or when ectoine is absent (18) . This apparent induction of trehalose synthesis by hydroxyectoine will be investigated in a further work. Finally, transfer of pHY-DROX2 to the ectoine-deficient strain CHR137 led to a much cleaner compatible solute profile, consisting of mainly hydroxyectoine and reduced amounts of glutamate and trehalose. Ectoine was not detected, although it should be present in minor amounts, as judged by our previous estimations (Table 1) .
In general, two alternative biological systems would be suitable to approach hydroxyectoine production: nonhalophilic microorganisms bearing hydroxyectoine synthesis genes and natural (halophilic) producers, either cultured in optimized conditions for solute production or metabolically engineered for hydroxyectoine overproduction (4). Table 2 summarizes most of the so-farreported hydroxyectoine production systems, including relevant Methanol-chloroform extraction This study a Maximum specific hydroxyectoine production rates were calculated on the basis of growth rates and biomass content. b Carrying the ectABCDask genes from P. tsutzeri DSM 5190 T . c Trehalose-deficient E. coli carrying the ectABCD genes from P. stutzeri A1501. d Trehalose-deficient E. coli carrying the ectABCDasK genes from P. stutzeri A1501. e With medium exchange once, during fed-batch. f Cells were first grown during 24 h at optimal salinity for biomass production (4.5% NaCl) and then transferred to a high-salinity medium (with 18.5% NaCl) for ectoines production. g Calculations for a maximum biomass of 61 g/liter. Fermentation was optimized for a simultaneous production of ectoine and hydroxyectoine. h Carrying the thpD (ectD) gene, encoding the ectoine hydroxylase from Streptomyces crysomallus. i Percentage of ectoine conversion to hydroxyectoine; absolute yield not reported. j Carrying the ectABCDD cassette from C. salexigens DSM 3043 T . k NR, not reported.
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February 2013 Volume 79 Number 3 aem.asm.org 1021 parameters such as growth conditions, hydroxyectoine yield and production rate, by-products, reactor systems, and product extraction procedures used. In this work, attempts to overproduce the C. salexigens ectABCD hydroxyectoine synthesis genes in E. coli DH5␣ were unsuccessful. It is possible that, as observed by Bestvater et al. (26) for the heterologous production of the Marinococcus halophilus ectoine synthesis genes, our heterologous production system might be improved by coexpressing a feedbackinsensitive aspartate kinase. This metabolic bottleneck was not found in the two reports so far describing successful hydroxyectoine production by E. coli carrying the hydroxyectoine synthesis genes from Pseudomonas stutzeri. However, differences in the osmotolerance conferred to the host strain, hydroxyectoine yield, presence of by-products, and the dependence of coexpresion of the ask gene for enhanced ectoine/hydroxyectoine production were found (17, 19) (Table 2) , Thus, the trehalose-deficient E. coli strain FF4169 bearing the P. stutzeri A1501 ectABCD genes accumulated moderate levels of ectoine and hydroxyectoine, and the introduction of the ask gene (encoding an aspartate kinase specialized for ectoine/hydroxyectoine synthesis) led to a very strong increase in the contents of both solutes (Table 2) . In both cases, host cells were osmoprotected (19) . In contrast, E. coli DH5␣ carrying the ectABCDask gene cluster from P. stutzeri DSM 5190
T synthesized almost exclusively hydroxyectoine as compatible solute (with about 5% of ectoine and trehalose), although conversion of ectoine into hydroxyectoine was delayed until late stationary phase. Surprisingly, this strain was not osmotolerant, and enhanced hydroxyectoine production was not dependent on coexpression of the aspartate kinase (17) . Despite all this, hydroxyectoine content was much higher than that observed in the natural producer, with a yield of 500 mol/g BDM (at stationary phase) and a specific production rate of 175 mol/g BDM · h at 37°C and 2% NaCl. Compared to this strain, the specific hydroxyectoine production rate of C. salexigens CHR137/pHYDROX2 grown at the same temperature with 4.35% NaCl was slightly lower [123.6 mol/g BDM · h], but the hydroxyectoine yield was much higher (883 mol/g BDM) ( Table 2) . For the industrial production of hydroxyectoine, robust microorganisms with a broad salt tolerance are favored to perform the bacterial milking process (3, 4) . Methods based on the Grampositive Marinococcus sp. strain M52 (20, 21) yielded considerable hydroxyectoine amounts at 37°C (Table 2 ) but had two disadvantages: (i) they cannot be milked by simple dilution of the medium, and (ii) they produce growth-inhibiting components such as acetate, which impede their use in batch and batch fermentation processes, unless complex techniques are utilized. Among Gramnegative bacteria of the Halomonadaceae family, C. salexigens (2), H. boliviensis (22) , and H. elongata (9, 24) naturally produce more ectoine than hydroxyectoine, and increasing the hydroxyectoine content implies high-temperature and -salinity growth conditions (Table 2) , with the disadvantages that these extreme conditions have for any industrial production system. In contrast, in P. stutzeri, hydroxyectoine is the predominant compatible solute at normal temperature (Table 2) , and this microorganism has been suggested as an interesting candidate for the biotechnological production of hydroxyectoine (19 (27) . On the basis of their phenotypic differences and their phylogenetic distance, strain H. elongata DSM 3043 was proposed as a new species of the genus Chromohalobacter and designated C. salexigens (7) . Although both species show a similar temperature range (from 15 to 45°C, with optimum at 37°C) and optimal salinity (8.7 to 11.6% NaCl) for growth (28, 29) , C. salexigens DSM 3043 seems to have more stringent requirements for salt. Thus, while the H. elongata type strain grew well with 0.3% NaCl in a minimal medium which is similar to M63 (29), C. salexigens could not grow at all in M63 unless it contained 2.9% NaCl (28) . There are few reports describing hydroxyectoine production by H. elongata. Early studies by Wohlfarth et al. (24) and Severin et al. (23) showed increasing hydroxyectoine content in H. elongata in response to salinity and temperature, with 290 mol/g BDM of hydroxyectoine (and 740 mol/g BDM of ectoine) in cells grown in glucose mineral medium at 40°C with 15% NaCl (Table 2 ). This yield is lower than the hydroxyectoine accumulated by the C. salexigens wild-type strain at 37 or 45°C with a similar salinity ( Table 2) . Unfortunately, hydroxyectoine production by H. elongata at temperatures higher than 40°C or specific hydroxyectoine production rates at 40°C or higher were not reported, making it difficult to compare production data among the two wild-type strains.
In this study, we describe hydroxyectoine overproduction by using recombinant strains of the natural producer C. salexigens genetically engineered (i) to coexpress, in a native-plasmid-based vector, the ectoine and hydroxyectoine genes under the control of the ectA promoter region, (ii) to improve the first approach by increasing the copies of ectD, and (iii) to further improve the two first designs by using an ectoine-deficient mutant as the genetic background. As stated above, transcriptional regulation of the C. salexigens ectABC genes for ectoine synthesis is rather complex, with a total of four promoters regulating ectABC transcription (two putative 70 -dependent promoters, one S -controlled promoter, and a fourth promoter of unknown specificity) and one putative 32 -dependent promoter driving ectBC expression. This multiplicity of promoters allows the cells to respond to many environmental stimuli such as high salinity and temperature and the presence of iron, external osmoprotectants, or the DNA gyrase inhibitor nalidixic acid (13) . In H. elongata ATCC 33173 T , Schwibbert et al. (30) found a different but also complex promoter assembly, with two transcriptional initiation sites upstream of ectA (corresponding to putative 70 -and S -dependent promoters), and a third one mapped immediately upstream of ectC, resembling 54 -controlled promoters. Based on these findings, the authors suggested that ectoine synthesis in H. elongata could be regulated not only by salinity but also by nitrogen supply. In addition, in the presence of the external osmoprotectant betaine, ectoine accumulation is totally abolished in C. salexigens (28) but not in H. elongata (24) , reflecting an apparently different regulation of ectoine production in both organisms. In summary, with the available data, it is difficult to predict if the same strategy followed in this study would efficiently work in H. elongata.
As stated above, the presence of by-products in any strain devoted to industrial production of hydroxyectoine is undesirable, as it would increase production costs (4) . All strains depicted in Table 2 that have been tested for the presence of other solutes show from trace (i.e., E. coli DH5␣/pSB01) to moderate (i.e., H. elongata, C. salexigens, or P. stutzeri wild-type strains) amounts of other contaminating solutes. Therefore, downstream processes involving a certain purification step are mostly unavoidable. For the most promising strain, CHR137/pHYDROX2, hydroxyectoine was the main product, which would be useful to reduce separation and purification costs. In any case, separation of hydroxyectoine from trehalose and glutamate is easy by simple chromatographic techniques (3, 9) .
Our findings indicate the superiority of the C. salexigens ectoine-minus strains over the wild-type strain for hydroxyectoine production, including much better yields and specific production rates than the wild type. Production achieved with strain CHR137/pHYDROX2 growing at a relatively low salinity, 4.35% NaCl, exceeds that of most other strains reported elsewhere ( Table  2 ). Its specific hydroxyectoine production yield is of the same order as that of heterologous production by E. coli DH5␣/pSB01 at 2% NaCl (17) , and the absolute yield is much higher. In addition, conversion of ectoine to hydroxyectoine by E. coli/pSB01 was much delayed until late stationary phase, whereas in C. salexigens production was maximal at early stationary phase. Nevertheless, E. coli DH5␣/pSB01 has the advantage of yielding purer hydroxyectoine. In addition, due to its natural ability to cope with strong changes in medium osmolarity, C. salexigens is a much more robust strain than E. coli for the industrial bacterial milking process, and therefore there is much room for improvement of hydroxyectoine production, for instance by continuous fermentation coupled to product extraction by osmotic downshocks. Thus, considering all relevant yield parameters, the C. salexigens recombinant strains are promising candidates for the biotechnological production of hydroxyectoine.
